BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

830 related articles for article (PubMed ID: 32391938)

  • 1. Role of exosomal microRNAs in lung cancer biology and clinical applications.
    Hu C; Meiners S; Lukas C; Stathopoulos GT; Chen J
    Cell Prolif; 2020 Jun; 53(6):e12828. PubMed ID: 32391938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-derived exosomal miR-619-5p promotes tumor angiogenesis and metastasis through the inhibition of RCAN1.4.
    Kim DH; Park S; Kim H; Choi YJ; Kim SY; Sung KJ; Sung YH; Choi CM; Yun M; Yi YS; Lee CW; Kim SY; Lee JC; Rho JK
    Cancer Lett; 2020 Apr; 475():2-13. PubMed ID: 32004570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of exosomal miRNA on cancer biology and clinical applications.
    Sun Z; Shi K; Yang S; Liu J; Zhou Q; Wang G; Song J; Li Z; Zhang Z; Yuan W
    Mol Cancer; 2018 Oct; 17(1):147. PubMed ID: 30309355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exosomal miRNAs as novel cancer biomarkers: Challenges and opportunities.
    Salehi M; Sharifi M
    J Cell Physiol; 2018 Sep; 233(9):6370-6380. PubMed ID: 29323722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoxic BMSC-derived exosomal miRNAs promote metastasis of lung cancer cells via STAT3-induced EMT.
    Zhang X; Sai B; Wang F; Wang L; Wang Y; Zheng L; Li G; Tang J; Xiang J
    Mol Cancer; 2019 Mar; 18(1):40. PubMed ID: 30866952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer exosomal microRNAs from gefitinib-resistant lung cancer cells cause therapeutic resistance in gefitinib-sensitive cells.
    Azuma Y; Yokobori T; Mogi A; Yajima T; Kosaka T; Iijima M; Shimizu K; Shirabe K; Kuwano H
    Surg Today; 2020 Sep; 50(9):1099-1106. PubMed ID: 32052182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exosome and exosomal microRNA: trafficking, sorting, and function.
    Zhang J; Li S; Li L; Li M; Guo C; Yao J; Mi S
    Genomics Proteomics Bioinformatics; 2015 Feb; 13(1):17-24. PubMed ID: 25724326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exosomal miRNAs as biomarkers of recurrent lung cancer.
    Munagala R; Aqil F; Gupta RC
    Tumour Biol; 2016 Aug; 37(8):10703-14. PubMed ID: 26867772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating exosomal microRNAs as prognostic biomarkers for non-small-cell lung cancer.
    Liu Q; Yu Z; Yuan S; Xie W; Li C; Hu Z; Xiang Y; Wu N; Wu L; Bai L; Li Y
    Oncotarget; 2017 Feb; 8(8):13048-13058. PubMed ID: 28055956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging roles of exosomal miRNAs in breast cancer drug resistance.
    Najminejad H; Kalantar SM; Abdollahpour-Alitappeh M; Karimi MH; Seifalian AM; Gholipourmalekabadi M; Sheikhha MH
    IUBMB Life; 2019 Nov; 71(11):1672-1684. PubMed ID: 31322822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exosomal microRNA: a novel biomarker for breast cancer.
    He Y; Deng F; Yang S; Wang D; Chen X; Zhong S; Zhao J; Tang J
    Biomark Med; 2018 Feb; 12(2):177-188. PubMed ID: 29151358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Exosomal Noncoding RNAs in Lung Carcinogenesis.
    Sun T; Kalionis B; Lv G; Xia S; Gao W
    Biomed Res Int; 2015; 2015():125807. PubMed ID: 26583084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological functions and clinical applications of exosomal long non-coding RNAs in cancer.
    Wang Y; Zhang M; Zhou F
    J Cell Mol Med; 2020 Oct; 24(20):11656-11666. PubMed ID: 32924276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exosomal microRNAs: novel players in cervical cancer.
    Nahand JS; Vandchali NR; Darabi H; Doroudian M; Banafshe HR; Moghoofei M; Babaei F; Salmaninejad A; Mirzaei H
    Epigenomics; 2020 Sep; 12(18):1651-1660. PubMed ID: 32957811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exosomal miR-106b serves as a novel marker for lung cancer and promotes cancer metastasis via targeting PTEN.
    Sun S; Chen H; Xu C; Zhang Y; Zhang Q; Chen L; Ding Q; Deng Z
    Life Sci; 2020 Mar; 244():117297. PubMed ID: 31954745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current Understanding of Exosomal MicroRNAs in Glioma Immune Regulation and Therapeutic Responses.
    Peng J; Liang Q; Xu Z; Cai Y; Peng B; Li J; Zhang W; Kang F; Hong Q; Yan Y; Zhang M
    Front Immunol; 2021; 12():813747. PubMed ID: 35095909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exosomal miRNAs as biomarkers for diagnostic and prognostic in lung cancer.
    Wu J; Shen Z
    Cancer Med; 2020 Oct; 9(19):6909-6922. PubMed ID: 32779402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exosomal microRNAs in non-small cell lung cancer.
    Duréndez-Sáez E; Torres-Martinez S; Calabuig-Fariñas S; Meri-Abad M; Ferrero-Gimeno M; Camps C
    Transl Cancer Res; 2021 Jun; 10(6):3128-3139. PubMed ID: 35116621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of Exosomal miRNAs in cancer.
    Li C; Zhou T; Chen J; Li R; Chen H; Luo S; Chen D; Cai C; Li W
    J Transl Med; 2022 Jan; 20(1):6. PubMed ID: 34980158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of exosomes in malignant glioma: microRNAs and proteins in pathogenesis and diagnosis.
    Ghaemmaghami AB; Mahjoubin-Tehran M; Movahedpour A; Morshedi K; Sheida A; Taghavi SP; Mirzaei H; Hamblin MR
    Cell Commun Signal; 2020 Aug; 18(1):120. PubMed ID: 32746854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.